Biodefense Stocks/ Homeland Defense Stock Alert; Dynasil Corporation trading at $6.26, up 2.50 (66.49%)

Point Roberts, WA - March 23, 2011 - Investorideas.com, a leader in investor sector research including Homeland Defense and Biodefense Stocks issues a trading alert on the sector as Dynasil Corporation of AmericaDYSL becomes the top gainer on the NASDAQ on patent news for its radiation monitoring device. Dynasil Corporation (NASDAQ GM:DYSL), announced today that its research division, Radiation Monitoring Devices, Inc. (RMD), also of Watertown, was granted additional U.S. patent claims for advances in a detector material capable of responding independently to both neutron and gamma radiation. This advancement is of critical national importance because the most commonly available technology for detecting neutrons in Homeland Security applications, specifically neutron detectors based on gaseous Helium-3, is becoming impractical because of serious limitations on the availability of this gas. In a recent article on Daily Finance entitled "Inside Wall Street: Looking to the Bio-Defense Sector as Nuclear Fears Mount”, notes - The sector attracted a lot of interest after 9/11 and a number of companies emerged to develop protective biodefense drugs and products. But with the waning of dark headlines about terrorist threats, investors have tended to put them on their low-priority list. That may be about to change Full article : http://www.dailyfinance.com/story/stock-picks/inside-wall-street-looking-to-bio-defense-sector-as-nuclear-fea/19880106/ Biodefense Stocks Sector Snapshot Aethlon Medical AEMD trading at $0.14 Dynasil Corporation (NASDAQ GM: DYSL) trading at $6.26, up 2.50 (66.49%) 12:21PM EDT Emergent Biosolutions, Inc. Com EBS trading at $23.53, down 0.04 (0.17%) 12:29PM EDT PharmAthene, Inc. (NYSE Amex: PIP) trading at $3.42, up 0.01 (0.29%) 12:27PM EDT Response Biomedical Corporation RBMRPBIF trading at $0.32 Siga Technologies SIGA trading at $12.27, up 0.25 (2.08%) 12:29PM EDT Research more Biodfense stocks at Investorideas.com http://www.investorideas.com/bds/stock_list.asp Biodefense Company Snapshot Aethlon Medical AEMD At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring. Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies. More: www.aethlonmedical.com Contacts: James A. Joyce Chairman, CEO 858.459.7800 x301 jj@aethlonmedical.com Visit the Aethlon Medical AEMD showcase page on Investorideas.com http://www.investorideas.com/CO/AEMD Get added to the company's news alerts: http://www.investorideas.com/Resources/Newsletter.asp About InvestorIdeas.com: InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com. Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011 Aethlon Medical AEMD :Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. 800-665-0411 - cvanzant@investorideas.com Source - Investorideas.com